IMAGO 7 FONDAZIONE DI RICERCA ONLUS

Their core work

IMAGO 7 is an Italian non-profit research foundation focused on advanced magnetic resonance imaging (MRI) techniques, operating at the intersection of physics, chemistry, and clinical medicine. Their core work involves developing quantitative and non-invasive MRI methods — moving beyond conventional anatomical imaging toward capturing biochemical processes inside the living body. In QuantMR7, they led research on magnetic resonance fingerprinting applied to the brain; in NICI, they joined a consortium pushing MRI-based chemistry imaging across the entire human body, with a specific focus on cancer detection and metabolomics. The "7" in their name almost certainly signals access to or expertise with 7 Tesla ultra-high-field MRI — a research-grade instrument that underpins their technical positioning.

What they specialise in

How they've shifted over time

Their first project (QuantMR7, 2016–2018) was narrowly focused on the brain — specifically using magnetic resonance fingerprinting to make MRI measurements more quantitative and reproducible. By 2018, their trajectory shifted dramatically outward: NICI extended the imaging scope to the whole human body and added an oncology application layer, pulling in metabolomics and 3D organoid models alongside the core MRI physics. The trend is from methodological physics research on a single organ toward integrated biochemical imaging with direct clinical utility in cancer — a meaningful maturation from tool development toward diagnostic application.

They are moving from technique development toward clinical translation, specifically in oncology imaging — making them a candidate partner for consortia that need both MRI physics expertise and biological/clinical grounding.

How they like to work

IMAGO 7 has shown both coordinator and partner roles across just two projects, which is notable for a small foundation — they led QuantMR7 independently and joined the larger NICI consortium as a participant. Their consortium size is modest (13 unique partners across 5 countries over two projects), suggesting they operate in focused, specialist partnerships rather than broad industrial alliances. Working with them likely means engaging a small, technically specialized team that can anchor an MRI or imaging work package.

IMAGO 7 has worked with 13 unique partners across 5 countries, a compact but internationally distributed network given only two projects. Their geographic spread across European countries — consistent with FET and MSCA funding — suggests connections to academic and research hospital partners rather than industrial networks.

What sets them apart

IMAGO 7 occupies a rare niche as a small, independent non-profit research foundation (ONLUS status signals public-interest mission) with demonstrated access to or expertise in ultra-high-field MRI — a capital-intensive and technically demanding instrument class. Unlike a university department, they can move faster and focus entirely on research without teaching obligations; unlike a hospital, they are not constrained by clinical workflow priorities. For a consortium needing credible MRI physics expertise combined with biological application knowledge in oncology, they bring a concentrated, mission-driven profile that larger institutions often lack.

Highlights from their portfolio

• NICI
  The largest project by EC funding (EUR 558,344), running five years and combining MRI physics with metabolomics and cancer biology — the most technically ambitious and clinically impactful project in their portfolio.
• QuantMR7
  Their coordinator role on a brain MRI fingerprinting project demonstrates independent project leadership capacity despite being a small foundation, and likely reflects access to 7 Tesla MRI infrastructure.